Trends and patterns of antibiotic consumption in China’s tertiary hospitals: Based on a 5 year surveillance with sales records, 2011-2015

PLoS ONE

Volumn 12, Issue 12, 2017, Pages

  Wushouer, Haishaerjiang ^a   Tian, Ye ^a   Guan, Xiao Dong ^a,b   Han, Sheng ^a,b   Shi, Lu Wen ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN; MACROLIDE; PARENTERAL SOLUTION; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT;

ARTICLE; CHINA; CONTROLLED STUDY; DRUG DOSAGE FORM; DRUG MARKETING; DRUG USE; DRUG UTILIZATION; EUROPE; GEOGRAPHIC DISTRIBUTION; HOSPITAL PATIENT; HUMAN; POPULATION RESEARCH; RETROSPECTIVE STUDY; RISK REDUCTION; TERTIARY CARE CENTER; TREND STUDY; COMMERCIAL PHENOMENA; DRUG UTILIZATION REVIEW; HEALTH SURVEY;

ANTI-BACTERIAL AGENTS; CHINA; COMMERCE; DRUG UTILIZATION REVIEW; EUROPE; HUMANS; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; TERTIARY CARE CENTERS;

EID: 85039557813     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0190314     Document Type: Article

References (35)

1. World Health Organization. Antimicrobial Resistance: Global Report on Surveillance, 2014. Available from: http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf
2. Earnshaw S, Mendez A, Monnet DL, Hicks L, Cruickshank M, Weekes L, et al. Global collaboration to encourage prudent antibiotic use. Lancet Infect Dis. 2013; 13(12): 1003–4. https://doi.org/10.1016/ S1473-3099(13)70315-3 PMID: 24252477
3. Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014; 14: 742–50. https://doi.org/10.1016/S1473-3099(14)70780-7 PMID: 25022435
4. Lin H, Dyar OJ, Rosales-Klintz S, Zhang J, Tomson G, Hao M, et al. Trends and patterns of antibiotic consumption in Shanghai municipality, China: a 6 year surveillance with sales records, 2009–14. J Antimicrob Chemother. 2016; 71: 1723–1729. https://doi.org/10.1093/jac/dkw013 PMID: 26892776
5. State Council of China. Opinions on Deepening the Reform of the Medical and Health Care System. 2009. Available from: http://www.china.org.cn/government/scio-press-conferences/2009-04/09/content_17575378.htm. Chinese.
6. Ministry of Health. National Guiding Principles for Antimicrobial Clinical Use. 2004. Available from: http://www.sda.gov.cn/WS01/CL0056/10752.html. Chinese.
7. Ministry of Health. Notification on Establishing China Antimicrobial Resistance Surveillance System and Center for Antibacterial Surveillance. 2005.
8. Ma X, Xie J, Yang Y, Guo F, Gao Z, Shao H, et al. Antimicrobial stewardship of Chinese ministry of health reduces multidrug-resistant organism isolates in critically ill patients: a pre-post study from a single center. BMC Infect Dis. 2016; 16(1): 704. https://doi.org/10.1186/s12879-016-2051-8 PMID: 27887595
9. Xiao Y, Li L. Legislation of clinical antibiotic use in China. Lancet Infect Dis. 2013; 13: 189–91. https://doi.org/10.1016/S1473-3099(13)70011-2 PMID: 23427881
10. Xiao Y, Li L. China’s national plan to combat antimicrobial resistance. Lancet Infect Dis. 2016; 16(11): 1216–1218. https://doi.org/10.1016/S1473-3099(16)30388-7 PMID: 27788972
11. World Health Organization. Anatomical Therapeutic Chemical (ATC) Classification System: Guidelines for ATC Classification and DDD Assignment. 2013. Available from: http://www.whocc.no/atc_ddd_index/
12. Vander Stichele RH, Elseviers MM, Ferech M, Blot S, Goossens H; ESAC Project Group. European Surveillance of Antimicrobial Consumption (ESAC): data collection performance and methodological approach. Br J Clin Pharmacol. 2004; 58: 419–28. https://doi.org/10.1111/j.1365-2125.2004.02164.xPMID: 15373935
13. Wushouer H, Tian Y, Guan XD, Han S, Shi LW. Trends and patterns of Antibiotic Consumption in China’s Tertiary Hospitals: based on a 5 year surveillance with sales records, 2011–2015. Available from: http://dx.doi.org/10.17504/protocols.io.ktkcwkw
14. European Center for Disease Prevention and Control. Surveillance of antimicrobial consumption in Europe 2012. 2014. Available from: http://ecdc.europa.eu/en/publications/Publications/antimicrobialconsumption-europe-esac-net-2012.pdf
15. Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997–2009). J Antimicrob Chemother. 2011; 66 Suppl 6:vi3–12.
16. Goossens H, Ferech M, Vander Stichele R, Elseviers M; ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005; 365: 579–87. https://doi.org/10.1016/S0140-6736(05)17907-0 PMID: 15708101
17. Ferech M, Coenen S, Malhotra-Kumar S, Dvorakova K, Hendrickx E, Suetens C, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. J Antimicrob Chemother. 2006; 58: 401–7. https://doi.org/10.1093/jac/dkl188 PMID: 16735414
18. Public Health England. English surveillance programme for antimicrobial utilization and resistance (ESPAUR) Report 2016. 2016. Available from: https://www.gov.uk/government/publications/english-surveillance-programme-antimicrobial-utilisation-and-resistance-espaur-report
19. Menet. Blue Book on the Development of China’s Medical and Pharmaceutical Market in 2015. Part of Terminal Market in Public Hospitals (II). Prog Pharm Sci. 2015; 39: 501–513.
20. National Health and Family Planning Commission of the People’s Republic of China. 2016 China Health Statistics Yearbook. Beijing: Peking Union Medical College Press; 2016.
21. Xiao Y, Zhang J, Zheng B et al. Changes in Chinese policies to promote the rational use of antibiotics. PLoS Med. 2013; 10: e1001556. https://doi.org/10.1371/journal.pmed.1001556 PMID: 24260030
22. Sun J, Shen X, Li M, He L, Guo S, Skoog G, et al. Changes in patterns of antibiotic use in Chinese public hospitals (2005–2012) and a benchmark comparison with Sweden in 2012. J Glob Antimicrob Resist. 2015; 3: 95–102. https://doi.org/10.1016/j.jgar.2015.03.001 PMID: 27873677
23. Bao L, Peng R, Wang Y, Ma R, Ren X, Meng W, et al. Significant reduction of antibiotic consumption and patients’ costs after an action plan in China, 2010–2014. PLoS One. 2015; 10: e118868.
24. Zhang QQ, Ying GG, Pan CG, Liu YS, Zhao JL. Comprehensive Evaluation of Antibiotics Emission and Fate in the River Basins of China: Source Analysis, Multimedia Modeling, and Linkage to Bacterial Resistance. Environ. Sci. Technol. 2015; 49: 6772−6782 https://doi.org/10.1021/acs.est.5b00729PMID: 25961663
25. European Centre for Disease Prevention and Control. Summary of the latest data on antibiotic consumption in the European Union. 2016. Available from: https://ecdc.europa.eu/sites/portal/files/documents/antibiotics-ESAC-Net%20Summary%202016_0.pdf
26. National Health and Family Planning Commission of the People’s Republic of China. The Administration on the Clinical Use of Antimicrobial Agents and the Status Quo of Antimicrobial Resistance in China. 1st ed. Beijing: Peking Union Medical College Press; 2016. Chinese.
27. National Health and Family Planning Commission of the People’s Republic of China. Notification on Launching National Regulatory Campaign of Clinical Application of Antibacterial Drugs. Available from: http://www.moh.gov.cn/mohyzs/s3586/201104/51376.shtml. Chinese.
28. van de Sande-Bruinsma N, Grundmann H, Verloo D, Tiemersma E, Monen J, Goossens H, et al. Antimicrobial Drug Use and Resistance in Europe. Emerg Infect Dis. 2008; 14(11): 1722–1730. https://doi.org/10.3201/eid1411.070467 PMID: 18976555
29. Public Health England. English surveillance programme for antimicrobial utilization and resistance (ESPAUR) Report 2016. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/575626/ESPAUR_Report_2016.pdf.
30. Centers for Disease Control and Prevention. Outpatient antibiotic prescriptions—United States. Available from: https://www.cdc.gov/getsmart/community/pdfs/annual-reportsummary_2014.pdf.
31. Hicks LA., Bartoces MG, Roberts RM, Suda KJ, Hunkler RJ, TH Jr, et al. US Outpatient Antibiotic Prescribing Variation According to Geography, Patient Population, and Provider Specialty in 2011. Clin Infect Dis. 2015; 60(9): 1308–16. https://doi.org/10.1093/cid/civ076 PMID: 25747410
32. Meyer E, Gastmeier P, Deja M, Schwab F. Antibiotic consumption and resistance: data from Europe and Germany. Int J Med Microbiol. 2013; 303(6–7): 388–95. https://doi.org/10.1016/j.ijmm.2013.04.004PMID: 23727396
33. Department of Medical Administration and Committee of Experts on Rational Drug Use, National Health and Family Planning Commission of the People’s Republic of China. National Antimicrobial Therapy Guidance. 1st ed. Beijing: People’s Medical Publishing House Co Ltd; 2012. Chinese
34. National Health and Family Planning Commission of the People’s Republic of China. Notification on Implementation of “Guidelines for Clinical Application of Antimicrobial Agents”. Available from: http://www.moh.gov.cn/wsb/pzcjd/200804/21154.shtml. Chinese.
35. Coenen S, Ferech M, Haaijer-Ruskamp FM, Butler CC, Vander Stichele RH, Verheij TJ, et al. European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe. Qual Saf Health Care. 2007; 16: 440–5. https://doi.org/10.1136/qshc.2006.021121 PMID: 18055888